Clinical and Functional Outcome of the MobileLink Acetabular Cup System in the Short-, Mid-, and Longterm Follow-up
Waldemar Link GmbH & Co. KG
520 participants
May 4, 2021
OBSERVATIONAL
Conditions
Summary
The implantation of artificial hip joints is one of the most frequently performed surgeries. Normally, patients are very satisfied with the results. The MobileLink hip prosthesis system is a CE marked medical device. This means the the safety and performance of the prosthesis ist approved. Aim of the study is to collect clinical data about the outcome of the MobileLink hip prosthesis system under routine condition and to determine the satisfaction of the patients.
Eligibility
Inclusion Criteria3
- Implantation of a MobileLink acetabular cup system and a femoral stem manufactured by Waldemar Link
- Age ≥ 18 years
- Fully signed patient informed cons
Exclusion Criteria6
- Revisions
- Body Mass Index (BMI) ≥ 40 kg/m²
- Patient who is foreseeable not able to understand the study and the study-related circumstances
- Patients who is foreseeable non-compliant to the treatment and the follow-ups
- Pregnant or breast-feeding women
- Prisoner
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Patients who receive a MobileLink hip prosthesis system will be followed-up for 10 years.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04688593